Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Jan 3, 2020

Total Value ($000): $966,300,626 (100.0% shares, 0.0% debt)

Holdings (33)

SPARK THERAPEUTICS INC 8.7%
Value ($000) $83,722,834 Shares 863,300 Est. Cost $60.22 Unrealized
INVITAE CORP 7.7%
Value ($000) $73,965,737 Shares 3,838,388 Est. Cost $10040.39 Unrealized
CDXS CODEXIS INC 7.2%
Value ($000) $69,586,892 Shares 5,073,780 Est. Cost $13.94 Unrealized +12.8%
BLUEPRINT MEDICINES CORP 7.1%
Value ($000) $69,061,800 Shares 940,000 Est. Cost $9221.69 Unrealized
SRPT SAREPTA THERAPEUTICS INC 6.9%
Value ($000) $66,281,600 Shares 880,000 Est. Cost $121.78 Unrealized -3.0%
MYOKARDIA INC 6.0%
Value ($000) $58,147,250 Shares 1,115,000 Est. Cost $39.07 Unrealized
BLUEBIRD BIO INC 5.8%
Value ($000) $56,239,750 Shares 612,500 Est. Cost $39167.43 Unrealized
SAGE THERAPEUTICS INC 5.8%
Value ($000) $56,116,000 Shares 400,000 Est. Cost $89.71 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 5.0%
Value ($000) $48,252,000 Shares 600,000 Est. Cost $81.37 Unrealized -2.8%
BLFS BIOLIFE SOLUTIONS INC 4.2%
Value ($000) $40,374,993 Shares 2,428,571 Est. Cost $15.38 Unrealized +22.0%
FATE FATE THERAPEUTICS INC 4.1%
Value ($000) $39,601,500 Shares 2,550,000 Est. Cost $4.33 Unrealized +342.9%
MAGENTA THERAPEUTICS INC 3.2%
Value ($000) $31,273,721 Shares 3,048,121 Est. Cost $1903.17 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 3.1%
Value ($000) $30,294,000 Shares 935,000 Est. Cost $52.35 Unrealized -20.9%
AUDENTES THERAPEUTICS INC 2.5%
Value ($000) $24,157,400 Shares 860,000 Est. Cost $26.14 Unrealized
CDNA CAREDX INC 2.3%
Value ($000) $22,610,000 Shares 1,000,000 Est. Cost $24.45 Unrealized +13.3%
GENMARK DIAGNOSTICS INC 2.1%
Value ($000) $20,391,900 Shares 3,365,000 Est. Cost $6.69 Unrealized
VYGR VOYAGER THERAPEUTICS INC 2.0%
Value ($000) $19,414,171 Shares 1,128,075 Est. Cost $14.86 Unrealized
ILMN ILLUMINA INC 1.9%
Value ($000) $18,253,200 Shares 60,000 Est. Cost $196.93 Unrealized +49.7%
GRITSTONE ONCOLOGY INC 1.6%
Value ($000) $15,283,950 Shares 1,770,000 Est. Cost $4096.07 Unrealized
HOMOLOGY MEDICINES INC 1.5%
Value ($000) $14,842,000 Shares 820,000 Est. Cost $11091.79 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.5%
Value ($000) $14,556,000 Shares 300,000 Est. Cost $32.45 Unrealized
ADPT ADAPTIVE BIOTECHNOLOGIES COR 1.5%
Value ($000) $14,310,562 Shares 463,125 Est. Cost $44.30 Unrealized -7.9%
SGMO SANGAMO THERAPEUTICS INC 1.4%
Value ($000) $13,167,750 Shares 1,455,000 Est. Cost $8.80 Unrealized +27.5%
ALEC ALECTOR INC 1.2%
Value ($000) $11,695,182 Shares 811,039 Est. Cost $19.01 Unrealized -5.1%
DNLI DENALI THERAPEUTICS INC 1.0%
Value ($000) $9,958,000 Shares 650,000 Est. Cost $20.48 Unrealized -6.7%
CONSTELLATION PHARMCETICLS I 1.0%
Value ($000) $9,844,782 Shares 1,523,960 Est. Cost $6.31 Unrealized
EDIT EDITAS MEDICINE INC 1.0%
Value ($000) $9,437,100 Shares 415,000 Est. Cost $29.14 Unrealized -15.0%
TWST TWIST BIOSCIENCE CORP 0.7%
Value ($000) $7,164,000 Shares 300,000 Est. Cost $26.45 Unrealized +9.9%
FULC FULCRUM THERAPEUTICS INC 0.6%
Value ($000) $5,606,052 Shares 844,285 Est. Cost $11.06 Unrealized 0.0%
ORCHARD THERAPEUTICS PLC 0.4%
Value ($000) $3,682,800 Shares 310,000 Est. Cost $12560.65 Unrealized
DECIPHERA PHARMACEUTICALS IN 0.4%
Value ($000) $3,394,000 Shares 100,000 Est. Cost $33940.00 Unrealized
TURNING POINT THERAPEUTICS I 0.3%
Value ($000) $2,820,000 Shares 75,000 Est. Cost $40080.00 Unrealized
STOK STOKE THERAPEUTICS INC 0.3%
Value ($000) $2,793,700 Shares 130,000 Est. Cost $27.21 Unrealized +2.5%